by According to Precedence Research, during the forecast period of 2022 to 2030, the global pharmacy benefit management market is estimated to develop at a compound annual growth rate (CAGR) of 5.5%. The global pharmacy benefit management market was valued at USD 467.58 billion in 2021, and it is predicted to exceed USD 757.05 billion by 2030. The study investigates several elements and their consequences on the growth of the pharmacy benefit management market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1770
This report focuses on pharmacy benefit management market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall pharmacy benefit management market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Pharmacy Benefit Management Market
| Report Coverage | Details |
| Market Size by 2030 | USD 757.05 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.5% |
| Largest Market | Asia Pacific |
| Fastest Growing Region | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Service, Service Provider, Business Model, Region |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of pharmacy benefit management, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of pharmacy benefit management has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the pharmacy benefit management market.
Some of the prominent players in the pharmacy benefit management market include:
- CVS Health
- SS&C Technologies, Inc.
- Anthem Inc.
- Medimpact
- Express Scripts Holding Company
- Benecard Services, LLC
- CaptureRx Inc.
- Change Healthcare
- OptumRx, Inc.
- Cigna
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1770
Segments Covered in the Report
By Service
- Specialty Pharmacy Services
- Benefit Plan Design & Administration
- Formulary Management
- Pharmacy Claims Processing
- Others
By Service Provider
- Retail Pharmacies
- Insurance Companies
- Standalone Pharmacy Benefit Management Providers
By Business Model
- Government Health Programs
- Employer-sponsored Programs
- Health Insurance Management
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmacy Benefit Management Market
5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmacy Benefit Management Market, By Service
8.1. Pharmacy Benefit Management Market, by Service, 2022-2030
8.1.1 Specialty Pharmacy Services
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Benefit Plan Design & Administration
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Formulary Management
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Pharmacy Claims Processing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmacy Benefit Management Market, By Service Provider
9.1. Pharmacy Benefit Management Market, by Service Provider, 2022-2030
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Insurance Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Standalone Pharmacy Benefit Management Providers
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmacy Benefit Management Market, By Business Model
10.1. Pharmacy Benefit Management Market, by Business Model, 2022-2030
10.1.1. Government Health Programs
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Employer-sponsored Programs
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Health Insurance Management
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmacy Benefit Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
Chapter 12. Company Profiles
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SS&C Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Anthem Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medimpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Express Scripts Holding Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Benecard Services, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CaptureRx Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Change Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OptumRx, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Cigna
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1770
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
